Portfolio company
CEVEC Pharmaceuticals GmbH
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops human cell line expression systems and viral vector manufacturing platforms for pharmaceutical and biotechnology organisations producing biotherapeutics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CEVEC
The company produces human cell-based expression systems and viral vector manufacturing technologies for biopharmaceutical firms and biotechnology organisations developing therapeutic proteins and gene therapies.
SIRION Biotech
The company develops and manufactures viral vector technologies for researchers and pharmaceutical firms in the cell and gene therapy sectors.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
GenVec
This clinical-stage biotechnology company develops gene-based therapeutics and vaccines using a proprietary delivery platform for the biopharmaceutical industry.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
CePep AB
This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.
Fuse Vectors
This company develops a cell-free enzymatic platform to manufacture viral vectors for pharmaceutical and biotechnology clients to produce gene therapies.
PharmaCell
The company provides contract manufacturing and development services for cell and gene therapy products to pharmaceutical and biotechnology clients.
